Evaluation of pulmonary artery bleeding during thoracoscopic pulmonary resection for lung cancer
© 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd..
BACKGROUND: Bleeding from the pulmonary artery (PA) can be fatal in video-assisted thoracoscopic surgery (VATS) for lung cancer. We evaluated intraoperative PA injury and assessed precautions for thoracoscopic anatomic pulmonary resection.
METHODS: We retrospectively analyzed a total of 1098 patients who underwent radical surgery for lung cancer utilizing complete VATS from January 2010 to December 2021.
RESULTS: A total of 16 patients (1.5%) had PA injury during VATS, while hemostasis was performed by conversion to thoracotomy in eight patients (50.0%). Although there was a significantly greater operation time and blood loss for patients in the PA injury group (318.4 vs. 264.9 min, p = 0.001; 550.3 vs. 60.5 g, p ≤ 0.001, respectively), there was no significant different for the chest tube insertion duration and length of postoperative hospital stay (4.9 vs. 7.8 days, p = 0.157; 10.6 vs. 9.9 days, p = 0.136, respectively). There was a significant difference observed for the surgical procedure related to the left upper lobectomy in the PA injury group (43.8 vs. 18.8%, p = 0.012), with the primary causative PA determined to be the left anterior segmental PA (A3 ) (31.3%).
CONCLUSIONS: VATS is both feasible and safe for lung cancer treatment provided the surgeon performs appropriate hemostasis, although fatal vascular injury could potentially occur during VATS. Surgeons need to be aware of the pitfalls regarding PA dissection management.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Thoracic cancer - 13(2022), 21 vom: 17. Nov., Seite 3001-3006 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tomoyasu, Makoto [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 04.11.2022 Date Revised 05.01.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/1759-7714.14649 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM34631481X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM34631481X | ||
003 | DE-627 | ||
005 | 20231226031135.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/1759-7714.14649 |2 doi | |
028 | 5 | 2 | |a pubmed24n1154.xml |
035 | |a (DE-627)NLM34631481X | ||
035 | |a (NLM)36114752 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tomoyasu, Makoto |e verfasserin |4 aut | |
245 | 1 | 0 | |a Evaluation of pulmonary artery bleeding during thoracoscopic pulmonary resection for lung cancer |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.11.2022 | ||
500 | |a Date Revised 05.01.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. | ||
520 | |a BACKGROUND: Bleeding from the pulmonary artery (PA) can be fatal in video-assisted thoracoscopic surgery (VATS) for lung cancer. We evaluated intraoperative PA injury and assessed precautions for thoracoscopic anatomic pulmonary resection | ||
520 | |a METHODS: We retrospectively analyzed a total of 1098 patients who underwent radical surgery for lung cancer utilizing complete VATS from January 2010 to December 2021 | ||
520 | |a RESULTS: A total of 16 patients (1.5%) had PA injury during VATS, while hemostasis was performed by conversion to thoracotomy in eight patients (50.0%). Although there was a significantly greater operation time and blood loss for patients in the PA injury group (318.4 vs. 264.9 min, p = 0.001; 550.3 vs. 60.5 g, p ≤ 0.001, respectively), there was no significant different for the chest tube insertion duration and length of postoperative hospital stay (4.9 vs. 7.8 days, p = 0.157; 10.6 vs. 9.9 days, p = 0.136, respectively). There was a significant difference observed for the surgical procedure related to the left upper lobectomy in the PA injury group (43.8 vs. 18.8%, p = 0.012), with the primary causative PA determined to be the left anterior segmental PA (A3 ) (31.3%) | ||
520 | |a CONCLUSIONS: VATS is both feasible and safe for lung cancer treatment provided the surgeon performs appropriate hemostasis, although fatal vascular injury could potentially occur during VATS. Surgeons need to be aware of the pitfalls regarding PA dissection management | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a left anterior segmental pulmonary artery (A3) | |
650 | 4 | |a pulmonary artery injury | |
650 | 4 | |a vascular stapler | |
650 | 4 | |a video-assisted thoracoscopic surgery | |
700 | 1 | |a Deguchi, Hiroyuki |e verfasserin |4 aut | |
700 | 1 | |a Kudo, Satoshi |e verfasserin |4 aut | |
700 | 1 | |a Shigeeda, Wataru |e verfasserin |4 aut | |
700 | 1 | |a Kaneko, Yuka |e verfasserin |4 aut | |
700 | 1 | |a Yoshimura, Ryuichi |e verfasserin |4 aut | |
700 | 1 | |a Kanno, Hironaga |e verfasserin |4 aut | |
700 | 1 | |a Saito, Hajime |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Thoracic cancer |d 2010 |g 13(2022), 21 vom: 17. Nov., Seite 3001-3006 |w (DE-627)NLM251832414 |x 1759-7714 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2022 |g number:21 |g day:17 |g month:11 |g pages:3001-3006 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/1759-7714.14649 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2022 |e 21 |b 17 |c 11 |h 3001-3006 |